A. Ephrem

Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanisms.

S. Kaveri, S. Lacroix-Desmazes, M. Kazatchkine, 2006, International immunopharmacology.

Intravenous immunoglobulin in neurological disorders: a mechanistic perspective

S. Kaveri, S. Lacroix-Desmazes, M. Kazatchkine, 2005, Journal of Neurology.

Modulation of Treg cells/T effector function by GITR signaling is context–dependent

D. Glass, E. Shevach, A. Epstein, 2013, European journal of immunology.

Intravenous immunoglobulin and dendritic cells

S. Kaveri, S. Lacroix-Desmazes, M. Kazatchkine, 2005, Clinical reviews in allergy & immunology.

Immunoglobulin-Dependent Regulation of Dendritic Cells in the Context of Autoimmune Responses

S. Kaveri, S. Dasgupta, J. Bayry, 2005, Transfusion Medicine and Hemotherapy.

Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis.

S. Kaveri, S. Lacroix-Desmazes, M. Kazatchkine, 2008, Blood.

Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin

S. Lacroix-Desmazes, M. Kazatchkine, S. Dasgupta, 2005, Clinical and Experimental Medicine.

Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.

S. Kaveri, S. Lacroix-Desmazes, M. Kazatchkine, 2007, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.